Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · IEX Real-Time Price · USD
15.04
-0.09 (-0.59%)
Jul 22, 2024, 10:38 AM EDT - Market open
Assembly Biosciences Employees
Assembly Biosciences had 65 employees as of December 31, 2023. The number of employees decreased by 3 or -4.41% compared to the previous year.
Employees
65
Change (1Y)
-3
Growth (1Y)
-4.41%
Revenue / Employee
n/a
Profits / Employee
-$790,077
Market Cap
92.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
LakeShore Biopharma | 773 |
Xtant Medical Holdings | 215 |
Asensus Surgical | 209 |
Aclaris Therapeutics | 91 |
Eton Pharmaceuticals | 30 |
Eupraxia Pharmaceuticals | 29 |
Checkpoint Therapeutics | 23 |
ASMB News
- 7 days ago - Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop - GlobeNewsWire
- 6 weeks ago - Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 - GlobeNewsWire
- 2 months ago - Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024 - GlobeNewsWire
- 2 months ago - Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 4 months ago - Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 5 months ago - Assembly Biosciences Announces Effective Date of Reverse Stock Split - GlobeNewsWire
- 7 months ago - Assembly Biosciences Provides Anticipated Development Milestones for 2024 - GlobeNewsWire
- 9 months ago - Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire